Thor Explorations Ltd. (LON:THX – Get Rating) insider Adrian J. G. Coates sold 110,925 shares of the stock in a transaction that occurred on Tuesday, May 31st. The stock was sold at an average price of GBX 18 ($0.23), for a total transaction of £19,966.50 ($25,261.26). Shares of THX opened at GBX 18.50 ($0.23) on […]
Athersys (NASDAQ:ATHX – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Athersys, Inc., a late stage biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs […]
Athersys (NASDAQ:ATHX – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Athersys, Inc., a late stage biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs […]
Thor Explorations (LON:THX – Get Rating)‘s stock had its “buy” rating reiterated by Canaccord Genuity Group in a research report issued to clients and investors on Monday, MarketBeat Ratings reports. Shares of LON:THX opened at GBX 18.23 ($0.24) on Monday. Thor Explorations has a 12 month low of GBX 12.50 ($0.16) and a 12 month […]
Zacks Investment Research downgraded shares of Athersys (NASDAQ:ATHX – Get Rating) from a buy rating to a hold rating in a report published on Tuesday, Zacks.com reports. According to Zacks, “Athersys, Inc., a late stage biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are […]